Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels - Erem, C; Nuhoglu, I; Yilmaz, M (J Endocrinol Invest, 2009)